<code id='5CBB7E2A8F'></code><style id='5CBB7E2A8F'></style>
    • <acronym id='5CBB7E2A8F'></acronym>
      <center id='5CBB7E2A8F'><center id='5CBB7E2A8F'><tfoot id='5CBB7E2A8F'></tfoot></center><abbr id='5CBB7E2A8F'><dir id='5CBB7E2A8F'><tfoot id='5CBB7E2A8F'></tfoot><noframes id='5CBB7E2A8F'>

    • <optgroup id='5CBB7E2A8F'><strike id='5CBB7E2A8F'><sup id='5CBB7E2A8F'></sup></strike><code id='5CBB7E2A8F'></code></optgroup>
        1. <b id='5CBB7E2A8F'><label id='5CBB7E2A8F'><select id='5CBB7E2A8F'><dt id='5CBB7E2A8F'><span id='5CBB7E2A8F'></span></dt></select></label></b><u id='5CBB7E2A8F'></u>
          <i id='5CBB7E2A8F'><strike id='5CBB7E2A8F'><tt id='5CBB7E2A8F'><pre id='5CBB7E2A8F'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:7
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          How Vertex's cystic fibrosis drug is changing patients' lives
          How Vertex's cystic fibrosis drug is changing patients' lives

          SusanUlan,right,greetshergranddaughterIvy,andherdaughterJessieAnderson,atAnderson'shome.SuzanneKreit

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Second xenotransplant done with gene

          TheUniversityofMarylandteampreparesthepigheartfortransplant.CourtesyUniversityofMarylandSchoolofMedi